Evaxion Announces Business Update and Third Quarter 2023
Christian Kanstrup joined Evaxion as Chief Executive Officer in SeptemberEvaxion has launched its refined strategy with an increased focus on value...
Source: globenewswire.com
📰 Comprehensive Loss Data News
Comprehensive Loss Data News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Comprehensive Loss Data. Real-time updates on events, politics, business and more.
Evaxion Announces Business Update and Third Quarter 2023 Financial Results
Christian Kanstrup joined Evaxion as Chief Executive Officer in SeptemberEvaxion has launched its refined strategy with an increased focus on value realization via partnerships based upon the...
United States Christian Kanstrup Andreas Holm Mattsson Afrigen Biologics Adnan Khattak Afrigen Join Forces For Gonorrhea
Source: marketscreener.com
Evaxion Announces Business Update and Third Quarter 2023 Financial Results
Christian Kanstrup joined Evaxion as Chief Executive Officer in SeptemberEvaxion has launched its refined strategy with an increased focus on valu...
United States Adnan Khattak Christian Kanstrup Andreas Holm Mattsson Afrigen Biologics Global Health Innovation Fund
Source: businessinsider.com
Evaxion Announces Business Update and Second Quarter 2023
Promising clinical data from Phase 1 and 2a studies with EVX-01 and EVX-02 were presented at AACR and ASCO in Q2 2023A novel proprietary genetic vaccine...
United States New York New Hampshire Securities Exchange Global Growth Holding Limited Exchange Commission
Source: globenewswire.com
Evaxion Announces Business Update and Second Quarter 2023 Financial Results
Promising clinical data from Phase 1 and 2a studies with EVX-01 and EVX-02 were presented at AACR and ASCO in Q2 2023A novel proprietary genetic vaccine adjuvant was presented at Evaxion’s R&D Day...
New Hampshire United States New York Global Growth Holding Limited Exchange Commission Staphylococcal Diseases Gordon Research Conference
Source: marketscreener.com
Evaxion Announces Business Update and First Quarter 2023 Financial Results
Finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
United States New York American Society For Clinical Oncology Exchange Commission Securities Exchange European Medicines Agency
Source: finanzen.ch
Evaxion Biotech: Fourth quarter and full year 2022 financial results and business update
Evaxion presented promising data from its Phase 1/2a clinical trial of EVX-02 in patients with late-stage melanoma at the 2023 AACR meetingEVX-03, a DNA-based personalized cancer vaccine, is expected to
New York United States European Medicines Agency Securities Exchange Program Overview Exchange Commission
Source: finanznachrichten.de
Investegate |Evaxion Biotech Announcements | Evaxion Biotech: Fourth quarter and full year 2022 financial results and business update
Investegate announcements from Evaxion Biotech, Fourth quarter and full year 2022 financial results and business update
United States New York Exchange Commission Us National Institutes Of Health Securities Exchange American Association For Clinical Research
Source: investegate.co.uk
Investegate |Evaxion Biotech Announcements | Evaxion Biotech: Evaxion Biotech Announces Second Quarter 2022 Financial Results and Provides Business Update
Investegate announcements from Evaxion Biotech, Evaxion Biotech Announces Second Quarter 2022 Financial Results and Provides Business Update
Source: investegate.co.uk
Evaxion Biotech Announces Second Quarter 2022 Financial Results and Provides Business Update
Expanded DNA oncology vaccine program into non-small cell lung cancer, NSCLCAnnounced successful production of personalized cancer immunotherapies for melanomaAnnounced gonorrhea as second bacterial product
Source: finanznachrichten.de